
News|Articles|January 1, 2009
Drug Watch: Agents in late-stage development for the treatment of depression and generalized anxiety disorder (January 2009) (PDF)
Agents in late-stage development for the treatment of depression and generalized anxiety disorder
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers discover new pathway to fight liver inflammation
2
Weekly autoinjector Leqembi is available for treatment initiation in Alzheimer’s
3
Employer health care costs projected to rise 9.5% in 2027, report finds
4
BE BOLD Efficacy and Safety Data: Comparing Bimekizumab and Risankizumab on Joint-Centric Endpoints
5
























